Overview
Rutger Meinsma practices in Amsterdam, Netherlands. Mr. Meinsma is rated as a Distinguished expert by MediFind in the treatment of Dihydropyrimidine Dehydrogenase Deficiency. His top areas of expertise are Dihydropyrimidine Dehydrogenase Deficiency, Early Infantile Epileptic Encephalopathy, Angelman Syndrome, and Neuroblastoma.
His clinical research consists of co-authoring 22 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Dihydropyrimidine Dehydrogenase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Dihydropyrimidine Dehydrogenase DeficiencyMr. Meinsma isDistinguished. Learn about Dihydropyrimidine Dehydrogenase Deficiency.
- Advanced
- Early Infantile Epileptic Encephalopathy
- Experienced
- Achalasia Microcephaly SyndromeMr. Meinsma isExperienced. Learn about Achalasia Microcephaly Syndrome.
- Angelman SyndromeMr. Meinsma isExperienced. Learn about Angelman Syndrome.
- Cortical DysplasiaMr. Meinsma isExperienced. Learn about Cortical Dysplasia.
- Embryonal Tumor with Multilayered Rosettes
- Gliomatosis CerebriMr. Meinsma isExperienced. Learn about Gliomatosis Cerebri.
- HypotoniaMr. Meinsma isExperienced. Learn about Hypotonia.